Papers
1
Total Citations
52
H-Index
1
About
Jiaqi Lin is a pioneering researcher at the intersection of biomedical engineering and pharmaceutical science, with a primary focus on developing advanced in vitro platforms for drug screening and tissue engineering. Their most notable contribution is the design and validation of a robotically handled whole-tissue culture system, detailed in their 2020 paper "Robotically handled whole-tissue culture system for the screening of oral drug formulations," which has garnered 52 citations. This innovative work addresses a critical bottleneck in preclinical drug development by enabling high-throughput, physiologically relevant testing of oral formulations using intact tissue samples, thereby reducing reliance on animal models and improving translational accuracy. Lin’s system integrates automated fluid handling, real-time monitoring, and precise environmental control, setting a new standard for reproducibility in tissue-based assays. Beyond this flagship study, Lin’s research portfolio spans microfluidic organ-on-a-chip devices, biomimetic scaffolds, and computational modeling of drug transport, all aimed at bridging the gap between in vitro and in vivo outcomes. Their work has been recognized for its potential to accelerate personalized medicine and has attracted interdisciplinary collaborations with clinicians and pharmaceutical partners. For students and researchers, Lin exemplifies how engineering ingenuity can transform fundamental biological questions into practical tools for drug discovery.
Research Focus
Key Achievements
Top Papers
- 1